Caricamento...
New insights into acquired endocrine resistance of breast cancer
The translational research strategy of targeting estrogen receptor α (ERα) positive breast cancer and then using long term anti-hormone adjuvant therapy (5-10 years) has reduced recurrences and mortality. However, resistance continues to occur and improvements are required to build on the success of...
Salvato in:
| Pubblicato in: | Cancer Drug Resist |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
OAE Publishing Inc.
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6897388/ https://ncbi.nlm.nih.gov/pubmed/31815253 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.20517/cdr.2019.13 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|